?Chapter 934:


    Kase spoke sincerely. “Miss Yount, you are talented, but you’re too young to grasp the harshness of reality. Theo from the Stephens Group once tried to develop targeted medicine for rare diseases but ultimately gave up.”


    “Mr. Stephens chose a different path. Surgery and medicine are equally crucial. He deserves our respect and admiration,” Flossie said.


    After her speech, Flossie nned to leave immediately. However, assistants from variouspanies pushed a stack of business cards into her hands, hoping she would reach out if she changed her mind.


    But if they didn’t change their stance, why would she change hers?


    Those business cards were destined to end up in the trash bin.


    As Flossie was leaving, she realized halfway through that she had forgotten something in the hall. When she returned, she saw a familiar figure talking to Kase.


    “Miss Yount, I was honest with you because I believe in your talent,” Kase said, thinking Flossie had reconsidered. “You can ask ML Sanders; developing new medicine for rare diseases has no future!”


    Flossie saw Levy, and her body tensed up involuntarily.


    “Well… Mr. Sanders, nice to meet you,” she said.


    “Long time no see, Miss Yount,” Levy greeted. He didn’t want to pretend he didn’t know Flossie.


    Flossie felt awkward and couldn’t find the right words. Kase, oblivious to the changed mood, focused on recruiting Flossie into hispany. “Mr. Sanders, please convince Miss Yount.”


    “Convince her of what?” Levy replied. “I think her idea is great.”


    Kase looked shocked as Levy turned to Flossie and offered, “Miss Yount, haven’t you been considering buying a biochemical analyzer? I’d like to sponsor you. Can you give me that chance?”


    Flossie was taken aback.


    Stories live now on g?lnσν???s.cοm


    Kase assumed that a new venture capitalist like Levy wanted to engage in charity by sponsoring Flossie’s unprofitable project. But it also highlighted Flossie’s worth.


    As Levy escorted Flossie outside, he asked, “Do you need a centrifugal concentrator? I have one as well.”


    “No,” Flossie said, staring at her toes. “Mr. Sanders, thank you for supporting me in front of Mr. Acosta, but you don’t need to invest in my unprofitable project.”


    Levy was a businessman, and as a businessman, it made sense that he wouldn’t support developing drugs for rare diseases. Flossie understood this.


    “Is someone else willing to help you, would you ept?”


    “Who?” Flossie was puzzled.


    “Theo.”


    “Of course!” Flossie’s eyes sparkled. “If Mr. Stephens coborates with us, it will be easier for patients to ess and understand the medicine, but… his group focuses on clinical treatment, not drug research and development.” Finally, Flossie sighed, acknowledging that this was why Theo had abandoned developing drugs for rare diseases.


    .


    .


    .